SCHEMBL7258386

SCHEMBL7258386

COC(=O)c1cnc(Nc2ccc3[nH]ncc3c2)nc1-c1ccc(OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.58
SYK P43405 4/20 0.55
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
TNIK Q9UKE5 1/20 0.54
ROCK1 Q13464 6/20 0.50
SMO Q99835 1/20 0.50
ROCK2 O75116 4/20 0.49
GSK3A P49840 2/20 0.48
GSK3B P49841 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
PRKG1 Q13976 1/20 0.48
IGF1R P08069 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PLK4 O00444 1/20 0.45
CHEK1 O14757 1/20 0.45
MAPK13 O15264 1/20 0.45
PDPK1 O15530 1/20 0.45
DAPK3 O43293 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7253637 0.92 KDR (0.58) KDRSYKNPC1RAB9ATNIK
SCHEMBL7253695 0.80 NPC1 (0.54) KDRSYKNPC1RAB9ATNIK
SCHEMBL3758727 0.75 ROCK2 (0.61) KDRSYKNPC1ROCK1ROCK2
SCHEMBL14607400 0.73 EGFR (0.61) KDRSYKNPC1RAB9AROCK1
SCHEMBL26506561 0.72 ULK1 (0.54) KDRSYKNPC1RAB9AROCK1
SCHEMBL15358459 0.72 KDR (0.61) KDRSYKNPC1RAB9AROCK1
SCHEMBL15349630 0.71 KDR (0.60) KDRSYKNPC1RAB9AROCK1
SCHEMBL12501409 0.71 SYK (1.00) KDRSYKSMOROCK2IGF1R
SCHEMBL5318416 0.71 TNIK (0.60) KDRSYKNPC1RAB9ATNIK
SCHEMBL15764664 0.71 NPC1 (1.00) NPC1RAB9AROCK1ROCK2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003030909-A1 2- AND 4-AMINOPYRIMIDINES N-SUBSTTITUDED BY A BICYCLIC RING FOR USE AS KINASE INHIBITORS IN THE TREATMENT OF CANCER BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-17 WO disclosed